Alcon Inc.
NYSE:ALCMedical - Instruments & Supplies
+$0.61 today
- Market cap
- $36.15B
- Beta
- 0.70
- P/E (TTM)
- 38.7
- EPS (TTM)
- $1.67
- Dividend yield
- 0.55%
Volume 4.74M
Average 1.91M
ALC Common Stock Issued
Cash raised by issuing new shares.
Alcon Inc.NYSE: ALC
Common Stock Issued · Q3 FY2026 · quarter ended Sep 2026
Common stock issued outflow grows to $0
Q3 FY2026 common stock issued was $0, compared with $0 a year earlier. Trailing-twelve-month common stock issued was $0.
Context
- Common stock issued amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Common stock issued increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly common stock issued holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Common Stock Issued vs competitors
How ALC compares with its peers on the latest reported figures
- ALC's LTM Sep 2026 common stock issued of $0 is the smallest of the 8 companies compared; the peer median is $1.89M.
- Common stock issued amounts to 0.0% of revenue for ALC, versus a peer median of 1.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $13.78M | -57.1% | +31.9% | 2.2% | |
| LTM Jul 2026 | $5.1M | -107.9% | -0.2% | 0.1% | |
| LTM Mar 2026 | $3.4M | -97.1% | -20.4% | 2.7% | |
| LTM Jun 2026 | $2M | — | — | 0.0% | |
| LTM Mar 2026 | $1.89M | +90.0% | +14.0% | 2.4% | |
| LTM Mar 2026 | $677K | +814.9% | -14.2% | 1.2% | |
| LTM Apr 2026 | $301K | -81.8% | +1413.7% | 0.1% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding ALC) | $1.89M | -69.4% | +6.9% | 1.2% | |
Competitors are the stored peer set for ALC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 376M | 335M | 974M | 1.02B | 980M |
| Depreciation & Amortization | 1.22B | 1.12B | 1.22B | 1.23B | 1.34B |
| Deferred Income Tax | 42M | 128M | (142M) | 238M | 180M |
| Stock-Based Compensation | 138M | 140M | 144M | 150M | 162M |
| Change in Working Capital | (314M) | (522M) | (431.22M) | (189M) | (240M) |
| Accounts Receivables | (198M) | (164M) | (117.41M) | (55M) | (129M) |
| Inventory | (326M) | (217M) | (289.26M) | (47M) | (156M) |
| Accounts Payables | 60M | (48M) | (54.44M) | (15M) | 116M |
| Other Working Capital | 150M | (93M) | 29.89M | (72M) | (71M) |
| Other Non-Cash Items | (116M) | 13M | (377.78M) | (368M) | (146M) |
| Operating Cash Flow | 1.35B | 1.22B | 1.39B | 2.08B | 2.27B |
| Capital Expenditures | (1.18B) | (745M) | (851M) | (670M) | (663M) |
| Acquisitions (Net) | 480M | (666M) | (10M) | (220M) | (700M) |
| Purchases of Investments | (19M) | (50M) | (248.7M) | (278M) | (136M) |
| Sales of Investments | 1M | 81M | 2M | 9M | 158M |
| Other Investing Activities | (480M) | (485M) | (177.3M) | (205M) | (123M) |
| Investing Cash Flow | (1.2B) | (1.87B) | (1.09B) | (1.17B) | (1.34B) |
| Debt Repayment | (63M) | 166M | (7M) | (137M) | (96M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (22M) | (50M) | (49M) | (47M) | (723M) |
| Dividends Paid | (54.11M) | (100M) | (116M) | (130M) | (166M) |
| Other Financing Activities | 16.11M | (24M) | (39M) | (8M) | (134M) |
| Financing Cash Flow | (123M) | (8M) | (211M) | (322M) | (1.12B) |
| Effect of Forex Changes | (6M) | 61M | 31M | (6M) | 43M |
| Net Change in Cash | 18M | (595M) | 114M | 582M | (149M) |
| Free Cash Flow | 165M | 472M | 537M | 1.41B | 1.61B |
Alcon Inc.
NYSE:ALC
Intrinsic Alpha fair value
Locked
Current Price
$75.26
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.